BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,360.40
      0.48%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.45
      0.00%
      Bitcoin
      92,173.85
      0.22%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. Biogen Inc (IDP) Quote

      Biogen Inc

      Biogen Inc (IDP)

      TG
      150.45
      -0.80001
      (-0.53%)
      Closed November 26 4:00PM
      Realtime Data

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      150.45
      Bid
      150.00
      Ask
      150.85
      Volume
      891
      149.05 Day's Range 152.60
      145.95 52 Week Range 245.20
      Market Cap
      21.923B
      Previous Close
      151.25
      Open
      150.75
      Last Trade
      4
      @
      150.35
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      739
      Shares Outstanding
      145,719,340
      Dividend Yield
      -
      PE Ratio
      19.79
      Earnings Per Share (EPS)
      7.97
      Revenue
      9.84B
      Net Profit
      1.16B

      About Biogen Inc

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.biogen.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker IDP. The last closing price for Biogen was 151.25 €. Over the last year, Biogen shares have traded in a share price range of 145.95 € to 245.20 €.

      Biogen currently has 145,719,340 shares outstanding. The market capitalization of Biogen is 22.04 € billion. Biogen has a price to earnings ratio (PE ratio) of 19.79.

      Ask ADVFN Intelligence (AI)

      IDP Latest News

      More News

      FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

      11 hours ago

      FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

      11 hours ago

      Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

      Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

      November 19 2024
      UK Regulatory

      Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

      Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

      November 14 2024
      UK Regulatory

      Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

      Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

      October 30 2024
      UK Regulatory

      Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

      Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

      October 29 2024
      UK Regulatory

      Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

      Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

      October 29 2024
      UK Regulatory

      Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

      Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

      October 28 2024
      UK Regulatory

      Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

      Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

      October 26 2024
      UK Regulatory

      Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

      Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

      October 24 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.51.00704941303148.94999155145.949991057149.89440712DE
      4-21.30001-12.4017525473171.75173.45145.949991469155.2600602DE
      12-34.45001-18.6316982153184.9186.95145.94999739161.60017063DE
      26-49.65001-24.8125987006200.1219.7145.94999579177.93429399DE
      52-61.75001-29.0999104618212.2245.2145.94999593192.5353003DE
      156-69.35001-31.5514149227219.8317.45145.94999561214.20622919DE
      260-121.90001-44.7585863778272.35351.7145.94999908243.23241358DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      2RZPoseida Therapeutics Inc
      8.90 €
      (225.77%)
      		48.28k
      GMEGeratherm Medic
      5.55 €
      (83.77%)
      		91.55k
      7S2Scotch Creek Ventures Inc
      0.0144 €
      (67.44%)
      		100k
      ZN80Hesai Group
      7.20 €
      (59.29%)
      		37.64k
      AXIAtos SE
      0.595 €
      (57.62%)
      		3.04M
      CHPCitigold Corporation Ltd
      0.001 €
      (-60.00%)
      		250k
      L7C2Windfall Geotek Inc
      0.0025 €
      (-54.55%)
      		500
      QN90Military Metals Corp
      0.278 €
      (-36.53%)
      		324.13k
      PKTMPIERER Mobility AG
      9.06 €
      (-35.74%)
      		173.35k
      0Z2Alector Inc
      2.44 €
      (-35.45%)
      		34.44k
      R1EAEV Resources Ltd
      0.002 €
      (25.00%)
      		4.8M
      D7GNel ASA
      0.272 €
      (1.12%)
      		3.14M
      AXIAtos SE
      0.595 €
      (57.62%)
      		3.04M
      PF8European Lithium Limited
      0.0168 €
      (0.00%)
      		2.96M
      3CPXiaomi Corporation
      3.2835 €
      (-5.40%)
      		2.09M

      Discussion

      View Full Feed
      janice shell janice shell 36 seconds ago
      Seriously, did anyone need Shkreli to tell them it was doomed? The follies of management should have been enough.
      SAVA
      Its_TradingG Its_TradingG 55 seconds ago
      I-Glow was actually here trying to keep people from wasting more money long before any talk of lawsuits and has been exposing the scam for over a year. Now the consensus from a few geniuses is that he's working with CCC to stop a lawsuit? lol OK whatever you guys say...
      ENZC
      tombe tombe 1 minute ago
      I kinda thought they went after a stop loss or two.
      ELTP
      ddls ddls 1 minute ago
      As usual the company is going after anything to save it. Only problem is they'll all end up failing. 😎

      Selling today 6 times buys.😎
      BIEL
      jimmybob jimmybob 2 minutes ago
      Afternoon rant -> https://www.optionmillionaires.com/jb-afternoon-rant-11-26-2024/
      janice shell janice shell 3 minutes ago
      His name didn't bode well...

      And did everyone see what happened to SAVA?

      https://investorshub.advfn.com/uimage/uploads/2024/11/26/gdecfimage.png

      Seems its Alzheimer's drug doesn't work. Which frankly shouldn't come as a huge surprise to anyone. The compan
      familyof5 familyof5 3 minutes ago
      No worries HoldEm777. Win, lose, or draw lol. That being said all is not lost just yet. Though it does feel like there are bigger and better opportunities out there as we sit and watch the paint dry here lol.
      VPER
      frrol frrol 4 minutes ago
      The company reiterates its "worldwide" plans in the PR, but leaves timing for next application unclear (after MAA acceptance, after CHMP opinion...) I suspect we'll get clarity at the FYE CC.
      AVXL
      infamous infamous 4 minutes ago
      Oh yea.? Howd that work out? Pedro should be strung up by his nuts
      TINO
      pennylandspirit pennylandspirit 4 minutes ago
      WHEN DOES THIS GO PENNYS?
      ASII
      crazy horse 0 crazy horse 0 5 minutes ago
      Yep all they want is WAR the people in these Countries better stand up

      Gads, the Deep State is F’Up !!
      learningcurve2020 learningcurve2020 5 minutes ago
      Perfect picture. 

      NWBO
      delerious1 delerious1 6 minutes ago
      I still say we get a NR tomorrow at 9AM...and it will be Material News....and likely even meteoric news, and if not tomorrow then likely Friday and if not Friday then....I could go on....
      NBRI
      deby hary deby hary 6 minutes ago
      noticed i cannot even post on eltp anymore ,without banning me officially .Where i seen this before ? Right , here on gnbt while all the arab goatfuckers dumping all their free shares on eltp ,no end insight https://www.youtube.com/watch?v=5abamRO41fE
      crescentmotor crescentmotor 7 minutes ago
      There could be other cayalysts such as PDD trial initiation or if they apply to other regulators such as FDA or as a smaller impact to UK, Canada, Aus/NZ or Japan.

      Yes. I'm not really expecting any near term progress with the FDA. Probably the last thing AVXL wants in the near term
      AVXL PDD
      Patrick Star Trader Patrick Star Trader 7 minutes ago
      Out of the goodness of your heart ❤️ eh?
      I’m camped 🏕️ out here also, but ain’t doing those things u talkin bout 🤔
      HIRU
      janice shell janice shell 7 minutes ago
      An investor says he put 98% of his retirement funds in Trump Media stock and won’t bail because Trump has a ‘secret’ plan

      Why is it that so many people seem to think plans are better if they're "secret"?
      bri123 bri123 7 minutes ago
      I bought 22M shares at $0.0001 today. It is my attempt to average down to a reasonable level for a (SLIM) chance of getting my money back.
      THBD
      SSKILLZ1 SSKILLZ1 7 minutes ago
      VMIR (As Of 11/26/24)

      Daily Performance
      Value Microcap Index:-2.08%
      Value Microcap Index Rebalanced:-1.67%

      Overall Performance
      Value Microcap Index: +25.30%
      Value Microcap Index Rebalanced:+29.26%
      SSKILLZ1 SSKILLZ1 8 minutes ago
      VMIR (As Of 11/26/24)

      Daily Performance
      Value Microcap Index:-2.08%
      Value Microcap Index Rebalanced:-1.67%

      Overall Performance
      Value Microcap Index: +25.30%
      Value Microcap Index Rebalanced:+29.26%
      XenaLives XenaLives 9 minutes ago
      From AI, it ain't that simple:


      While there is no direct evidence that fluoroquinolones directly cause vitamin B12 deficiency, some studies and medical opinions suggest that long-term use of antibiotics like fluoroquinolones could potentially contribute to a depletion of B vita
      XenaLives XenaLives 9 minutes ago
      From AI, it ain't that simple:


      While there is no direct evidence that fluoroquinolones directly cause vitamin B12 deficiency, some studies and medical opinions suggest that long-term use of antibiotics like fluoroquinolones could potentially contribute to a depletion of B vita
      wadegarret wadegarret 10 minutes ago
      TSSI- Is it worth a higher valuation than COHR ?

      TSSI gave guidance of eps for the next three quarters of around $.08/qtr. Since they made $.10 for Q3, that would mean $.24 more, or $.34 in eps for the year going forward vs a $9.44 stock price, or a PE of 28 going forward for
      COHR TSSI
      WebSlinger WebSlinger 10 minutes ago
      >

      I agree. I think that the NASDAQ will at least give them the benefit of the doubt and give them an extension.
      SMCI

      Your Recent History

      TG
      IDP
      Biogen
      Delayed Upgrade Clock